PINK1 Antikörper (N-Term)
Kurzübersicht für PINK1 Antikörper (N-Term) (ABIN363489)
Target
Alle PINK1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-50, N-Term
-
Spezifität
- Reacts with human, mouse and rat PINK1
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- An N-terminal region synthetic peptide made to the human PINK1 protein sequence (between residues 1-50).
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
WB(1:500) -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Tris-citrate, phosphate, ( pH 7-8) buffer, Sodium azide 0.1 %
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 4°C. Do not freeze.
-
-
- PINK1 (PTEN Induced Putative Kinase 1 (PINK1))
-
Andere Bezeichnung
- Pink1
-
Hintergrund
- Phosphatase and Tensin Homolog (PTEN) dephosphorylates lipids.Malfunctions in this contribute to many human cancers.PTEN induced putative kinase 1 (Pink1) was first discovered when researching the PTEN signaling pathway, thus Pink1 is also involved in many human cancers.It is found in the mitochondria and its homozygous C-terminus mutation has beenimplicated in the early development of Parkinson's disease.
-
Gen-ID
- 65018
-
Pathways
- Autophagie
Target
-